ERICA EZELL: Open Payments
NPI 1568025765 · ABERDEEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 14 companies in 2025. Trend: 2023 $65 · 2024 $421 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Dexcom, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, Kerendia, Dexcom G6 Transmitter, HETLIOZ, Auvelity, LEQVIO.
Industry payments across OH — which companies pay providers there.
